Name: Cancer Research 2023
Start: 2023-10-05
End: 2023-10-07
Location: Austria

Conference Information

Welcome Message

Cancer Research 2023 solicits the honor and pleasure of your support at the “30th International Conference on Cancer Research and Pharmacology” on October 05- 07, 22023 in Vienna, Austria. The theme of this conference is "Current Problems and Contemporary Perspectives in Cancer Research".

We're pleased to extend an expression of interest to you to join us for Cancer Research 2023 which will optimize partakers, and speakers during both business and social exchanges that are as pivotal as the sessions themselves.

Cancer Research 2023 intends to spread knowledge and new ideas among experts, scholars, and businesspeople working in the fields of Cancer Research and Pharmacology. Participants will share their findings and intrigue in lively conversations during the event. The program will include interactive, hands-on workshops and informative sessions in addition to the customary plenary, keynote, and oral abstract sessions.

The “30th International Conference on Cancer Research and Pharmacology” will encompass a broad spectrum of themes, including clinical trials, Immunotherapy, Epidemiology, Genetics and Epigenetics, Neurological cancer, Cancer Pharmacology, and recent advancements in Cancer research. An excellent chance to begin or advance current collaboration and understanding is handed by Cancer Research 2023. The information presented at this conference will be salutary to cancer victims across the world in the times ahead.

We look forward to your appearance in Vienna!!

About Conference

The 30th international conference on cancer research and pharmacology is scheduled to be held from October 05–07, 2023, in Vienna, Austria. It is being coordinated with the help of generous academics and editorial board members.

The Cancer Research Conference invites participants from each pioneering university, clinical research foundations, and illustrative companies to discuss their research experiences on all facets of this rapidly expanding topic, thereby showcasing the most recent approach. The objective of Cancer Research 2023 is to foster communication between experts, businesspeople, and students working in the field of cancer prevention and research.

Our program has been developed with your interests in mind as the primary event. We have included more networking chances for you as well as more targeted sessions that will include cutting-edge presentations, unique panel discussions, and lively interaction with industry leaders and experts.

Targeted Audiences:

Cancer research Students, Scientists
Cancer Researchers
Chemotherapists
Medical Devices Manufacturing Companies
Pharmaceutical Companies
Physicians
Radiologists
Cancer Associations and Societies
Cancer research Faculty
Medical Colleges
Oncologists
Business Entrepreneurs
Diagnostics Companies

Benefits for the attendees:

Discuss the concepts with mentors and reputable scholars.
Ideas are being pass back and forth at this conference. This is an incredible opportunity for you to present your thoughts and impart your extensive knowledge.
Young scientists will come to know about prominent, contemporary subjects during this Forum.

List of honors given to attendees:

Best Speaker Award
Best Poster Award
Young Scientist Award

An award should inspire participants to work hard to reach their maximum potential, which could benefit the field as a whole. A platform for collaboration among researchers for greater development.

Sessions/Tracks

TRACK 01: Cancer Research

Researchers developed a list of 11 cancer hallmarks and two enabling traits to better understand the underlying mechanisms. These hallmarks include self-sufficiency in growth signals, insensitivity to anti-growth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, tissue invasion, metastasis, reprogramming energy metabolism, and evading immune response in the Cancer research. Recently, the metastasis of cancer facilitate ANO1 modifies the metabolism of cholesterol and the tumor microenvironment.

Sub tracks:

Biology of Cancer
Cancer Management and Research
Covid and Its Impact on Cancer

Related Conferences:

Related Associations and Societies:

TRACK 02: Causes, Prevention, and Treatment

The development and expansion of cancer cells can occur for a variety of reasons. Many factors, including smoking, radiation, infections, cancer-causing synthetic substances (agents), weight, hormones, unending irritability, and a lack of movement, might alter quality. Cancer prevention refers to actions performed to reduce the risk of contracting the illness. This can involve maintaining a healthy lifestyle, learning about disease-causing agents, and taking medications or receiving vaccinations that can prevent the development of cancer. The causes of cancer might range from genetics to a person's lifestyle. There are techniques to treat or stop the spread of cancer, which can move from one part of the body to another and cause death.

Sub tracks:

Cancer Prevention
Treatments of Cancer
Causes of Cancer

Related Conferences:

Related Associations and Societies:

TRACK 03: Cancer Clinical Trials

Clinical trials for cancer compare the most popular and successful treatment for a particular kind or stage of the disease with an innovative strategy. There are studies to prevent cancer, enhance early diagnosis, prevent the disease from returning, lessen side effects, or enhance the quality of life, despite the fact that many studies concentrate on late-stage disease. Because of the development of novel drugs to prevent or manage Graft-Versus-Host Disease, clinical preliminary studies are widely observed for true advancements in cancer treatment (GvHD). Graft-Versus-Host Disease is a normal and theoretically severe reaction to stem cell transplantation in which donor-safe cells attack solid patient cells and tissues.

Sub tracks:

Case Reports on Cancer
Cancer Grades and Cancer Stages
Metastasis of Cancer

Related Conferences:

Related Associations and Societies:

TRACK 04: Cancer Genetics and Epigenetics

Cancer epigenetics focuses on changes to the cancer cell's genome that are epigenetic in nature but do not involve a change in the nucleotide sequence. Genetic and epigenetic changes have traditionally been viewed as two distinct pathways involved in the development of cancer. The surprising identification of numerous inactivating mutations in genes that regulate the epigenome was a recent result of whole exome sequencing of thousands of patient malignancies. Epigenetic changes play a crucial role in the transformation of normal cells into cancer cells, and manipulating them has significant potential for cancer therapy, detection, and prevention.

Sub tracks:

Histone modification
Genetic Alterations
Epigenetic Alterations

Related Conferences:

Related Associations and Societies:

TRACK 05: Nursing Oncology

Nursing Patients with cancer and those who are at risk for the disease will receive care from oncology. They examine physical problems, make treatment recommendations, and supervise chemotherapy and other cancer treatments. One of the most important and lucrative areas of nursing is cancer. Quiet evaluation is a vital component of cancer nurture. They are in charge of examining patients before, during, and after chemotherapy as well as surveying individuals who have begun due to treatment effects. The oncology training is essential for understanding pathological causes, their recommendations, and having a thorough understanding of the typical adverse effects of growth-promoting medications.

Sub tracks:

Sleep disorders
Speech Conditions
Pain medicine

Related Conferences:

Related Associations and Societies:

TRACK 06: Cancer Immunology

Cancer immunology examines the role of the immune system in the development and spread of cancer. Cancer immunotherapy is the most well-known use, which makes use of the immune system to treat cancer. Immunology describes, quantifies, and places into context the physiological functioning of the immune system in both healthy and diseased conditions; breakdowns of the immune system in immunological disorders, for instance: autoimmune diseases, hypersensitivities, immune deficiency, and rejection of transplants; and the physical, compound, and physiological attributes of the immune system's component parts in vitro, in situ, and in vivo. Immunology has uses in many different branches of medicine, particularly in the areas of dermatology, cancer, rheumatology, virology, bacteriology, parasitology, psychiatry, and organ transplantation.

Sub tracks:

Tumor Immunology
Auto-immunity
Transplantation immunology

Related Conferences:

Related Associations and Societies:

TRACK 07: Neuro-Oncology

Many nefarious personality disorders have been attributed to the central nervous system. The Central Nervous System includes information on the disease's mechanism, metastatic spread, ramifications, cancers, neurons and sensory receptors, neurological disorders, multiple sclerosis, and imaging agents to CNS neurofibromatosis. Cancer can spread to it directly or by pressing against continuous tissues. Medicines for the central nervous system are expected to rise at a CAGR of -3.2% from 2013 to 2018. The market for treatments for the central nervous system (CNS) is expected to grow to US$133 billion by 2018, as the prevalence of diseases rises as a result of population growth, the introduction of new medications, and rising healthcare costs.

Sub tracks:

Spinal cord Tumor
Brain abnormalities

Related Conferences:

Related Associations and Societies:

TRACK 08: Cancer Nanotechnology

Using nanotechnology to treat cancer has some intriguing potential outcomes, including the ability to detect and remove ill cells before they become tumors and the potential to remove cancerous tumors with minimum harm to healthy tissue and organs. One form of therapy under consideration is focused chemotherapy, which administers a tumor-executing drug called tumor rot factor alpha (TNF) to developing tumors. TNF and Thiol-derivatized Polyethylene Glycol (PEG-THIOL), which conceals the TNF-bearing nanoparticle from the resistant framework, are linked to a gold nanoparticle. As a result, the nanoparticle can safely traverse the circulatory system. Providing or enhancing radiotherapy.

Sub tracks:

Nanomaterials in Cancer Therapy
Current Nanomaterials in Nanomedicine
Functional Nanoparticles for Enhanced Cancer Therapy

Related Conferences:

Related Associations and Societies:

TRACK 9: Cancer Preventive Vaccines: Oncolytic Therapy & Others

Cancer vaccinations boost the body's immune system's ability to defend against potentially harmful infectious invaders. Cancer vaccinations come in two flavors: preventative and therapeutic. Preventative vaccines are used to stop the growth of cancer cells. Cancer cells are infected and destroyed by the oncolytic virus, whereas normal cells are not affected. Cancer cell eradication with chemotherapy and radiation therapy may be facilitated by oncolytic virus therapy. A targeted therapy of this kind is used. additionally referred to as viral therapy, oncolytic virotherapy, and virotherapy.

Sub tracks:

Hyperthermia
Immunotherapy
Photodynamic Therapy

Related Conferences:

Related Associations and Societies:

TRACK 10: Cancer Pathophysiology

Cancer is a group of illnesses marked by abnormal cell proliferation and the propensity to spread to other body organs or tissues. Tumors that originate in contrast to these do not spread. The warning signs and symptoms of Pathophysiology are a lump, unusual bleeding, a persistent cough, weight loss, and changes in bowel habits. About 22% of cancer fatalities can be attributed to tobacco use. 10% are due to obesity, a bad diet, a lack of exercise, or excessive alcohol and drug consumption. Additional factors include exposure to certain illnesses, ionizing radiation, and environmental contaminants.

Sub tracks:

Bacteria and Cancer
Virus and Cancer
Cancer and its Relevance with other Diseases

Related Conferences:

Related Associations and Societies:

TRACK 11: Organ-Defined Cancers

Cancer can affect any organ of the body. Lung, prostate, colon, rectum, stomach, brain, and liver cancer in males are the most prevalent types of the disease. The breast, colon, rectum, lung, cervix, ovary, and stomach are the most frequently affected by cancer in women. Often, the location of the cancer's origin is mentioned in descriptions of the disease. For increased accuracy, malignancies can also be categorized in accordance with the kind of cell from which the tumor cells originated because several body sections contain various tissue types. The type of cancer a person has must be correctly identified because different cancer types behave quite differently and react to different treatments.

Sub tracks:

Gut Microbiota Implications in Cancer
Prostate Cancer
Breast cancer

Related Conferences:

Related Associations And societies:

TRACK 12: Cancer Pharmacology

One of the greatest health challenges and the leading cause of death in every corner of the globe is cancer. Cancer pharmacology includes research on the fundamental mechanisms of signal transduction involved in cell proliferation and apoptosis, the application of anti-neoplastic agents, the formulation and discovery of new drugs, the fundamental mechanisms of DNA repair and DNA damage tolerance, and the development of creative gene therapy approaches. Over the next few of years, the global market for cancer medications is predicted to grow twice as quickly as other pharmaceutical markets. Several governmental agencies transform $6 billion in consumer spending.

Sub tracks:

Cancer Drugs Market
Cancer Metabolomics

Related Conferences:

Related Associations And societies:

TRACK 13: Cancer Epidemiology, Screening, Diagnosis & Prognosis

Cancer Pharmacology practices epidemiological methods. Cancer can be detected by disease screening before any symptoms appear. This could involve medical imaging, other tests, urine tests, blood tests, or other tests. Cancer screening tool using microfluidics. When a cancer first manifests, it is typically detected through screening, the existence of symptoms, or both. Both of these do not require a pathologist to evaluate a tissue test in order to reach a Definitive Diagnosis.

Sub tracks:

Infectious Disease Epidemiology
Neuro-Psychiatric Epidemiology
Cancer Detection and Diagnosis

Related Conferences:

Related Associations And societies:

TRACK 14: Radiology& Imaging in Cancer Diagnosis & Therapy

Radiation-damaged cancer cells either cease proliferating or pass away. Radiation works by creating minute breaks in the DNA within the cells, causing cancer cells to proliferate and divide more quickly than normal cells. Radiation can also have an adverse effect on the normal cell current surrounding cancer cells. Surgery, chemotherapy, immunotherapy, Pharmacology, and radiation therapy can all be combined with radiation therapy. Depending on cancer's nature and location, there are three different ways to administer radiation. Radiation comes in a variety of forms, including systemic, internal, and external.

Sub tracks:

Cancer Imaging Techniques
External Beam Radiation
Internal Beam radiation

Related Conferences:

Related Associations And societies:

TRACK 15: Innovations in Cancer Research

Anticancer medication is turning out to be a crucial strategy to combat the disease because tumor cells have evolved drug resistance to present treatments. Another significant step in the search for anticancer drugs may be CHK1. Particularly reliant on homeostasis-regulating molecular chaperones and associated proteins are cancer cells. These are potential targets for novel cancer treatments. Cancer is characterized by dysregulated apoptosis, and the Bcl-2 family of proteins is essential for controlling the course of this process. New anticancer medications can be developed in a substantial way by blocking their process. It is well known that several plant sources are significant sources of cutting-edge anti-cancer capabilities.

Sub tracks:

Advances in Cancer Research and Treatment
Role of AI in Cancer

Related Conferences:

Related Associations And societies:

TRACK 16: Exercise Oncology

There are several different physical fitness programs used in exercise oncology. a comprehensive program that concentrates on your whole body. In order to better understand how physical exercise affects cancer therapy and prognosis, the Exercise Oncology Service brings together physiologists and cancer researchers. Cancer patients and their primary care doctors have long been fascinated by the idea that anything as easy as possible can make cancer therapy more enjoyable and help patients recover more quickly after the treatment is over.

Sub tracks:

Post-operative rehabilitation
Strength Training

Related Conferences:

Related Associations And societies:

TRACK 17: Prostate Cancer

Males with prostate cancer are frequently diagnosed with the condition, especially those who are older. The disease is uncommon in men under the age of 40 or 45 and in places with affluent populations. Males frequently develop prostate cancer, although it is remarkably treatable in the early stages. The prostate gland, which is located between the penis and the bladder, is where it begins. While metastatic prostate cancer cannot be completely cured, it can be treated for a significant period of time, and some patients can even outlive the disease.

Sub tracks:

Adenocarcinoma
Transitional cell carcinoma
Squamous cell carcinoma
Small cell prostate cancer

Related Conferences:

Related Associations and Societies:

TRACK 18: Bio-markers of Cancer Stem Cells

The second most frequent and fifth most frequently examined cause of cancer death in men cancer malignant human tumours, is the primary histological subtype of liver cancers. Hepatocellular carcinoma is the common type of primary liver cancer. It is challenging to characterise HCC with a single biomarker despite the fact that many biomarkers have been demonstrated to have probable predictive importance and that numerous molecular markers are useful diagnostic tools for Hepatocellular carcinoma. Marks of a combination of biomarkers may therefore be more crucial for the detection, organisation, and visualisation of HCC.

Sub tracks:

Warning Signs of Cancer
Diagnostic biomarker
Prognostic biomarker
Stratification biomarker

Related Conferences:

Related Associations and Societies:

TRACK 19: Pharmacokinetics

The study of the timing of medication absorption, distribution, metabolism, and excretion is known as pharmacokinetics. Clinical pharmacokinetics is the application of pharmacokinetic concepts to the secure and successful therapeutic administration of medications in a particular patient. Clinical pharmacokinetics' main objectives are to improve a patient's pharmacological therapy's efficacy and reduce its toxicity. Clinicians may now apply pharmacokinetic principles to real-world patient scenarios thanks to the emergence of robust correlations between medication concentrations and their pharmacologic effects.

Sub tracks:

Absorption
Distribution
Metabolism
Excretion

Related Conferences:

Related Associations and Societies:

TRACK 20: Pharmacodynamics

Pharmacodynamics describes the link between medication concentration at the site of action and the subsequent effect, including the progression and severity of therapeutic and unfavourable effects. The interaction of a drug with a receptor at the site of action determines how that medication will behave. The pharmacodynamics of a drug can be influenced by several factors, including the level of drug target concentration and the downstream signaling pathways.

Sub tracks:

Drug-receptor interactions
Signal transduction
Dose-response relationships
Therapeutic index

Related Conferences:

Related Associations and Societies:

Market Analysis

The worldwide oncology market is expected to reach more than US$ 581.25 billion by 2030, with a substantial CAGR of 8.2% expected to take place between 2022 and 2030. In 2021, it was forecast to be worth US$ 286.04 billion. According to an article in Cancer Connect 2020, researchers from the Dana Farber Cancer Centre found that during the COVID-19 pandemic, diagnoses of the six most frequent cancer types- breast, colorectal, lung, pancreatic, gastric, Cancer Pharmacology, and oesophageal cancers- decreased by 46%. Global healthcare systems have been impacted by the COVID-19 pandemic, and the market for cancer therapies has also been significantly impacted. Additionally, it was advised to delay elective surgeries, cancer screenings, Cancer Drugs and other health prevention services unless the risks outweighed the benefits, according to the Centres for Disease Control and Prevention (CDC), as well as to prepare the hospital's infrastructure for the care of COVID-19 patients. In this way, the COVID-19 pandemic has affected the market for cancer therapies.

Latest developments

Significant improvements in the field of oncology have been made recently. The new treatments frequently have fewer adverse effects and are more efficient than the ones currently in use. The early detection of cancer has also shown hints of improvement. The fact that they are frequently less expensive is wonderful news for people who are having trouble affording their care. By identifying tumors sooner when they are most curable, new technologies like PET scans and blood testing are assisting physicians. A lot of progress has been made in cancer, and new cures and treatments are constantly being created and evaluated

Pharmaceutical medications are governed by a plethora of laws and rules that determine the size and growth rates of the market and deal with patenting, testing, safety, efficacy, and marketing. They can serve as entrance obstacles for small businesses, along with the significant R&D expenses related to developing new medicinal solutions. Yet, pharmaceutical firms create both branded and generic medications. Smaller competitors have opportunities with generics, which are copies of pharmaceuticals whose patents have expired. Particularly in underdeveloped nations where governments support their manufacturing to increase access to less expensive therapies, they are capturing a larger market share.

Cancer Diagnostics & Treatment Insights

In 2020, the oncology market was dominated by the cancer therapy segment, which drew in around 56% of the market. This is a result of standard chemotherapy and immunotherapy being used more consistently to treat cancer regionally. The most opportunistic segment, according to estimates, is cancer diagnostics. The desire of more individuals to recognize cancer as soon as feasible is boosting the cancer diagnostics market's expansion. Throughout the projection period, this segment's expansion is forecasted to be propelled by the widespread availability of easy and non-invasive diagnostic technologies The population's rising sense of the condition of cancer is driving demand for cancer diagnostics around the world.

Indication Insights

The market was dominated by the lung cancer category in 2021, as a result of an increase in lung cancer incidences worldwide. Over 1.8 million deaths from lung cancer were documented in 2020, according to the International Association for Research on Cancer. Of the world's population, lung cancer is the cancer type that is most quiet often diagnosed, and it is responsible for around 18% of all cancer fatalities. The worldwide pharmacy market is being driven by a number of factors, including the ageing population, the increase in ill consumers, and the widening selection of prescriptions. Between FY 2019–20 and FY 2020–21, pharmaceuticals expenses in the UK increased by 3.46 percent, according to Countrywide Health Services. It is acknowledged as the main cause that individuals die from cancer. An important element driving the growth of this market is the rising incidence of smoking across the globe. Between 2015 and 2018, more than 20% of Americans took more than three drugs, according to the Centres for Disease Control and Prevention, which estimates that 45.7% of People used at least ones.

Region Insights

In terms of global oncology sales in 2021, North America was in the lead. The rising incidence of cancer in developed nations like the US is to blame for this. Almost 1.8 million new instances of cancer and 606,520 fatalities were recorded in the US in 2020, according to the American Cancer Society. Lung cancer, and prostate cancer, colorectal cancer, breast cancer are the most common types of cancer in North America. The presence of sophisticated healthcare infrastructure and rising healthcare costs would likely help the North American oncology industry maintain its prominence. Since 1991, there have been a little over 29% fewer cancer fatalities in the US thanks to the increased use of oncology treatments.

Johnson & Johnson is another key competitor in the pharmaceuticals market in 2023. The company has previously created a cutting-edge Covid-19 vaccination for the medication that is widely used in the US. Several medical goods, including vaccines, have also contributed to the rise in drug sales of this multinational corporation. The Moderna is a start-up that was only established in 2010, and the fact that they have been able to increase their level of pharmacy revenue over time is a credit to their dedication to the community and ongoing hard work.

The pharmaceutical industry's outlook

By 2023, the pharmaceutical industry will be worth $1.57 trillion globally, predicts NAVADHI research. Forecasting market growth is a typical process that takes into account a number of variables, such as historical growth patterns, market drivers, present and forthcoming trends, and market barriers. Europe, which presently makes up 20.24 percent of the global pharmaceutical business, is predicted to lose market share by 2023. With a market share of 24.07 percent, the Asia-Pacific pharmaceuticals sector is anticipated to keep its second-place ranking in 2023. Increasing its market share from 45.33 percent in 2017 to 45.33 percent in 2023, North America is anticipated to continue to dominate the world's pharmaceutical market.. The area is predicted to serve.

Key Takeaway

In 2021, 46.8% of the market share was accounted for by the cancer diagnostic segment
Between 2022 and 2030, the hospital sector will expand at a CAGR of 10.9%
The market for breast cancer in 2021 was estimated to be USD 57.23 billion
By 2021, the North American market share had risen to 46.2%
The pharmaceutical market will experience the quickest growth until 2021 in the area of drugs for the treatment of diseases of the thyroid and pituitary glands as well as metabolic disorders like diabetes. Despite a recent rise of 11.6%, this market category will continue to develop at a rate of 9% per year in the future and will hold the fifth-largest market share

Oncology Market Report Coverage

The report: “Oncology Market Forecast (2020-2030)”, by Industry ARC, covers an in-depth analysis of the following segments of the Oncology Market
By Cancer Type: Pathophysiology, Pharmacology, Nanotechnology, Nursing Oncology, Cancer Immunology and others
By Therapy Type: Radiation Oncology, Medical Oncology, Surgical Oncology, Others
By Geography: South America, North America, Europe, Asia-Pacific, and Rest of the World

Past Conference Report

On May 19, 2021, PULSUS held the "29th International Conference on Cancer Research and Pharmacology" as a Webinar. This conference incorporated the most influential speaker, “Soldano Ferrone” who gave inspirational talks and lead practical Workshops

We would like to express our gratitude to everyone who helped make this conference a success on behalf of the organizing committee. All individuals who participated in the conference-attendees, speakers, chairs, and co-chairs from many countries were greatly appreciated for their contributions.

The conference would like to extend its sincere gratitude to the members of the organizing committee for their swift outreach to a number of outside experts and corporate enterprise councils, as well as to other significant people who interacted with us and supported the conference in every manner. Without their support, the convention might not have been feasible. Every part of the conference was reinforced, making it impossible for the convention to take place. Remembering this motto, which was motivated by your response, made Cancer Research 2021 succeed.

With the success of our previous Cancer Research 2021 event, we are delighted to present the next "30th International Conference on Cancer Research and Pharmacology," which will be held on October 05-07, 2023 in Vienna, Austria.